Egrifta SV Dosage
Generic name: TESAMORELIN ACETATE 2mg in 0.5mL;
Dosage form: kit
Drug class: Growth hormones
Medically reviewed by Drugs.com. Last updated on Dec 12, 2024.
Dosage and Administration
• The dosage and administration recommendations in this prescribing information only apply to EGRIFTA SV (tesamorelin) for injection 2 mg per vial formulation. For dosage and administration recommendations for tesamorelin for injection 1 mg per vial formulation, see the EGRIFTA prescribing information. These two formulations and strengths have differences in the dosage, the number of vials required to prepare a dose, reconstitution instructions, and storage requirements.
• The dose of EGRIFTA SV is 1.4 mg, 0.35 mL of the reconstituted solution, injected subcutaneously once daily.
• Inject EGRIFTA SV into the abdomen. Rotate injection sites to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.
Reconstitution Procedure
• Instruct patients to read the Instructions for Use enclosed in the EGRIFTA SV Medication Box.
• Use only the diluent provided, Sterile Water for Injection, to reconstitute EGRIFTA SV.
• Reconstitute 1 vial of EGRIFTA SV lyophilized powder with 0.5 mL of diluent (2 mg per 0.5 mL). Mix by rolling the vial gently in your hands for 30 seconds. Do not shake.
• Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Use only if the solution is clear, colorless and without particulate matter.
• Administer 0.35 mL of EGRIFTA SV immediately following reconstitution and throw away any unused solution and diluent. If not used immediately, discard the reconstituted solution. Do not freeze or refrigerate the reconstituted solution.
More about Egrifta (tesamorelin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (20)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Myalept
Myalept (metreleptin) is used to treat complications caused by leptin deficiency in people who have ...
Genotropin
Genotropin is a human growth hormone used to treat growth failure in children and adults who lack ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Humatrope
Humatrope injection (somatropin) is a human growth hormone used to treat growth failure in children ...
Ngenla
Ngenla is a long-acting human growth hormone used to treat children aged 3 and older who are not ...
Norditropin
Norditropin is used to treat growth hormone deficiency (GHD) in adults and children and other ...
Norditropin FlexPro
Norditropin FlexPro is used for adult human growth hormone deficiency, idiopathic short stature ...
Nutropin
Nutropin is used for adult human growth hormone deficiency, growth retardation, chronic renal ...
Nutropin AQ
Nutropin AQ (somatropin) is an injectable preparation that may be used to treat children with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
